Matches in Nanopublications for { ?s ?p "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP936605.RAnuU7ip6w-gwXLtfXP6nbVKNgE7Y1RMv-N9eWKAHTLKM130_assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP936605.RAnuU7ip6w-gwXLtfXP6nbVKNgE7Y1RMv-N9eWKAHTLKM130_provenance.
- assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP414987.RAmjuKp9uwHRML8STrphzHAzjRa2NdJslL8noPmwFgmrE130_assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP414987.RAmjuKp9uwHRML8STrphzHAzjRa2NdJslL8noPmwFgmrE130_provenance.
- NP843973.RAt1YMql0DDh2S39DfMt_yPWbf6NAuWRHsBsYRYn6nSFo130_assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843973.RAt1YMql0DDh2S39DfMt_yPWbf6NAuWRHsBsYRYn6nSFo130_provenance.
- NP843977.RAtWHPagcxvlywfDZsFrz-xiP4GsqUHCZ5WlrzDz9MN7g130_assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843977.RAtWHPagcxvlywfDZsFrz-xiP4GsqUHCZ5WlrzDz9MN7g130_provenance.
- NP1016556.RAMqJknmPbfrXQgfq9UmGTbjLWf0j5-19DrUiRmnoDsQk130_assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1016556.RAMqJknmPbfrXQgfq9UmGTbjLWf0j5-19DrUiRmnoDsQk130_provenance.
- NP896171.RAPdcPXj0uZRPlgi13Mfh469O3CFBhNJkY-2hXD98dWMs130_assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896171.RAPdcPXj0uZRPlgi13Mfh469O3CFBhNJkY-2hXD98dWMs130_provenance.
- NP843980.RAJPS4lKq2YqFjiFlUxJWBiGLhunv8ZOFpkRvKQq5n6H4130_assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843980.RAJPS4lKq2YqFjiFlUxJWBiGLhunv8ZOFpkRvKQq5n6H4130_provenance.
- NP843979.RA2q7V8tBjS6jUhHKK0lK1NH1ceUnqAnWLoIOOM6_um5A130_assertion description "[Successful retargeting of herpes simplex virus type 1 (HSV-1) has been achieved using vectors that carry a modified envelope glycoprotein D (gD) engineered to interact directly with novel receptors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP843979.RA2q7V8tBjS6jUhHKK0lK1NH1ceUnqAnWLoIOOM6_um5A130_provenance.